PEX2 is an integral peroxisomal membrane protein with two transmembrane domains and a cytosol-facing zinc RING domain. It functions as an E3 ubiquitin ligase, tagging peroxisomal membrane proteins for degradation during amino acid starvation or basal turnover . Antibodies targeting PEX2 enable researchers to study its localization, expression, and role in peroxisomal dynamics.
Target: Peroxisomal Biogenesis Factor 2 (PEX2), also known as PXMP3.
Applications: Western blotting (WB), immunohistochemistry (IHC), immunofluorescence (IF), and ELISA.
Reactivity: Primarily human, with cross-reactivity in rodent, cow, dog, guinea pig, horse, and rabbit models .
Western Blotting:
Immunohistochemistry (IHC):
Immunofluorescence (IF):
Peroxisomal Disorders: Mutations in PEX2 cause Zellweger syndrome and infantile Refsum disease. Antibodies aid in diagnosing these conditions .
Pexophagy Studies: PEX2 antibodies confirm its role in autophagy receptor NBR1-mediated peroxisome degradation .
Knockdown/Rescue Experiments: PEX2 siRNA depletion abolishes starvation-induced pexophagy in HeLa cells, rescued by siRNA-resistant PEX2 constructs .
Peroxisomal Isolation: PEX2 is enriched in medium/heavy fractions of purified peroxisomes, distinct from ER/mitochondrial markers .
Positive Controls: Use HEK293 cells overexpressing PEX2-FLAG or PMP34-GFP to confirm specificity .
Off-Target Risks: Polyclonal antibodies may bind non-specific epitopes. Blocking peptides or pre-absorption recommended .
Preservatives: Sodium azide in some formulations poses handling risks .
Species Variability: Reactivity with non-human models (e.g., cow, dog) requires experimental validation .
Zellweger Spectrum: PEX2 mutations (e.g., C247R, W223X) disrupt peroxisome assembly, leading to neurodevelopmental defects .
Diagnostic Utility: Antibodies enable detection of aberrant PEX2 expression in patient-derived cells .